ACAD

ACADIA PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.15

EPS Forecast

$251

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31

Market expectations

EPS Expectation:

$0.15

Revenue Expectation:

$251

EPS Surprise Expectation:

$0.019

Revenue Surprise Expectation:

$2

Post-release price volatility - High

Post-release Overnight Move:

±9.8%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: